Efficacy of BIBF 1120 in patients with IPF is dose-dependent: Results from the TOMORROW trial
Year: 2011
Type: article
Source: European Respiratory Journal
Institutions: Ruhrlandklinik, University of Duisburg-Essen, University of Modena and Reggio Emilia, Instituto Nacional de Enfermedades Respiratorias, Asan Medical Center, National Jewish Health, University of Michigan, Michigan Medicine, Duke University, Duke Medical Center, University of Washington, Boehringer Ingelheim (France), Boehringer Ingelheim (Germany), Imperial College London
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1775621272
